|12 Months Ended|
Feb. 01, 2020
|Other Assets, Noncurrent [Abstract]|
|Other Assets||Other Assets
(1) Amounts are net of an accumulated impairment loss of $9 million.
Our indefinite-lived intangible assets primarily consist of our worldwide rights for the Liz Claiborne® family of trademarks and related intellectual property. In connection with our annual indefinite-lived intangible assets impairment tests performed during the fourth quarter of 2019, we did not record an impairment for our indefinite-lived intangible assets as the estimated fair values exceeded the carrying values of the underlying assets.
Tabular disclosure of noncurrent assets.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef